---
title: 'The U.S. Health-Care System Found a Way to Make Peanuts Cost $4,200'
layout: LinkPost
date: 2019-09-19T22:13:54.197Z
excerpt: >-
  In other words, based on what is currently known, the billion-dollar peanut
  powder is likely to have a net effect of increasing severe allergic reactions
  to peanuts. The fact that this drug is so close to becoming a household
  name—despite so little evidence—reflects a broader shift in how drugs are
  approved. The old standard was that a drug could not be taken to market until
  it had proved to be safe and effective in two trials with meaningful end
  points—ideally treating or curing a disease, or at least alleviating symptoms.
  Over the past decade, the FDA has loosened standards, requiring only some
  evidence of an effect that may or may not be meaningful
link: >-
  https://www.theatlantic.com/health/archive/2019/09/dangers-peanut-allergy-drug/597997/
---

